Tech Company M&A Transactions
Iomed Acquisition
On 5/18/2007, Iomed was purchased by ReAble Therapeutics. Financial terms set the valuation at $22 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/18/2007
Transaction Type
M&A
Amount
$22,000,000
M&A Terms
ReAble will acquire all the outstanding shares of IOMED in an all-cash merger for $2.75 per share, subject to adjustment. The total transaction consideration will be approximately $22 million. The all-cash merger represents a premium of approximately 38% over the average closing price over the last 30 trading days.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2441 South 3850 West
Salt Lake City, UT 84120
USA
Salt Lake City, UT 84120
USA
Phone
Website
Email Address
Not Recorded
Overview
IOMED, Inc. engages in the development, manufacture, and marketing of drug delivery systems used primarily to treat acute local inflammation in the physical and occupational therapy, and sports medicine markets in the United States and internationally. It offers iontophoresis technology primarily for transdermal drug delivery and for the treatment of ophthalmic disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Lollini
Browse more venture capital transactions:
Prev: 5/18/2007: Vivaldi BioSciences venture capital transaction
Next: 5/20/2007: AquaPure Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs